[Evaluation of delayed-action Tebonin with the study of muscle flow, using xenon 133].
D000328:Adult; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D001783:Blood Flow Velocity; D003692:Delayed-Action Preparations / Q000627:therapeutic use; D005419:Flavonoids / Q000627:therapeutic use*; D006801:Humans; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000098:blood supply*; D010936:Plant Extracts / Q000627:therapeutic use; D011868:Radioisotopes; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014978:Xenon
D003692:Delayed-Action Preparations; D005419:Flavonoids; D010936:Plant Extracts; D011868:Radioisotopes; D014665:Vasodilator Agents; D014978:Xenon
Valutazione del Tebonin retard con lo studio del flusso muscolare mediante 133 xenon.